Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Prescribed Exercise to Be Carried Out at Home
Pattee, Gladys

Canadian Journal of Occupational Therapy | March 27, 2013 | Volume: 8 | Issue: 2 | Pages: 36-42

10.1177/000841744100800203 Get It

Relationships between Occupational Therapy and Physical Medicine and Rehabilitation
Krusen, Frank H.

Canadian Journal of Occupational Therapy | March 27, 2013 | Volume: 21 | Issue: 1 | Pages: 3-9

10.1177/000841745402100101 | PMID 13160858 Get It

Ticlopidine‐associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)
Bennett, Charles L. , Jacob, Sony, Dunn, Brianne L., Georgantopoulos, Peter , Zheng, X. Long , Kwaan, Hau C. , McKoy, June M. , Magwood, Jametta, Qureshi, Zaina P. , Bandarenko, Nicholas, Winters, Jeffrey L. , Raife, Thomas J. , Carey, Patricia M. , Kiss, Joseph E. , Danielson, Constance, Clark, William F. , Ablin, Richard J., Rock, Gail, Fujimura, Yoshihiro , Sarode, Ravi , Ortel, Thomas L. , Rock, Gail, Matsumoto, Masanori , Winters, Jeffrey L , Zheng, X Long

British Journal of Haematology | March 27, 2013 | Volume: 161 | Issue: 6 | Pages: 896-898

10.1111/bjh.12303 | PMID 23530950 Get It

Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium
Ryan, Zachary C. , McNulty, Melissa S. , McGee‐Lawrence, Meghan E. , Craig, Theodore A., Grande, Joseph P. , Kumar, Rajiv , Ketha, Hemamalini , Westendorf, Jennifer J. , Singh, Ravinder J. , Kumar, Rajiv , McGee-Lawrence, Meghan E

Proceedings of the National Academy of Sciences | March 27, 2013 | Volume: 110 | Issue: 15 | Pages: 6199-6204

10.1073/pnas.1221255110 | PMID 23530237 Get It

Inactivating mutations of the SOST (sclerostin) gene are associated with overgrowth and sclerosis of the skeleton. To determine mechanisms by which increased amounts of calcium and phosphorus are accreted to enable enhanced bone mineralization in the absence of sclerostin, we measured concentrations of calciotropic and phosphaturic hormones, and urine and serum calcium and inorganic phosphorus in mice in which the sclerostin ( sost ) gene was replaced by the β-D-galactosidase ( lacZ ) gene in the germ line. Knockout (KO) ( sost −/− ) mice had increased bone mineral density and content, increased cortical and trabecular bone thickness, and greater net bone formation as a result of increased osteoblast and decreased osteoclast surfaces compared with wild-type (WT) mice. β-Galactosidase activity was detected in osteocytes of sost KO mice but was undetectable in WT mice. Eight-week-old, male sost KO mice had increased serum 1α,25-dihydroxyvitamin D, decreased 24,25-dihydroxyvitamin D, decreased intact fibroblast growth factor 23, and elevated inorganic phosphorus concentrations compared with age-matched WT mice. 25-Hydroxyvitamin D 1α-hydroxylase cytochrome P450 ( cyp27B1 ) mRNA was increased in kidneys of sost KO mice compared with WT mice. Treatment of cultured proximal tubule cells with mouse recombinant sclerostin decreased cyp27B1 mRNA transcripts. Urinary calcium and renal fractional excretion of calcium were decreased in sost KO mice compared with WT mice. Sost KO and WT mice had similar serum calcium and parathyroid hormone concentrations. The data show that sclerostin not only alters bone mineralization, but also influences mineral metabolism by altering concentrations of hormones that regulate mineral accretion.
Transgenic overexpression of ribonucleotide reductase improves cardiac performance
Nowakowski, Sarah G., Kolwicz, Stephen C. , Korte, F. Steven, Luo, Zhaoxiong, Robinson-Hamm, Jacqueline N. , Page, Jennifer L. , Brozovich, Frank V. , Tian, Rong , Weiss, Robert S. , Murry, Charles E. , Regnier, Michael , Brozovich, Frank V

Proceedings of the National Academy of Sciences | March 27, 2013 | Volume: 110 | Issue: 15 | Pages: 6187-6192

10.1073/pnas.1220693110 | PMID 23530224 Get It

We previously demonstrated that cardiac myosin can use 2-deoxy-ATP (dATP) as an energy substrate, that it enhances contraction and relaxation with minimal effect on calcium-handling properties in vitro, and that contractile enhancement occurs with only minor elevation of cellular [dATP]. Here, we report the effect of chronically enhanced dATP concentration on cardiac function using a transgenic mouse that overexpresses the enzyme ribonucleotide reductase (TgRR), which catalyzes the rate-limiting step in de novo deoxyribonucleotide biosynthesis. Hearts from TgRR mice had elevated left ventricular systolic function compared with wild-type (WT) mice, both in vivo and in vitro, without signs of hypertrophy or altered diastolic function. Isolated cardiomyocytes from TgRR mice had enhanced contraction and relaxation, with no change in Ca 2+ transients, suggesting targeted improvement of myofilament function. TgRR hearts had normal ATP and only slightly decreased phosphocreatine levels by 31 P NMR spectroscopy, and they maintained rate responsiveness to dobutamine challenge. These data demonstrate long-term (at least 5-mo) elevation of cardiac [dATP] results in sustained elevation of basal left ventricular performance, with maintained β-adrenergic responsiveness and energetic reserves. Combined with results from previous studies, we conclude that this occurs primarily via enhanced myofilament activation and contraction, with similar or faster ability to relax. The data are sufficiently compelling to consider elevated cardiac [dATP] as a therapeutic option to treat systolic dysfunction.
TIMP-1 Attenuates Blood–Brain Barrier Permeability in Mice with Acute Liver Failure
Radisky, Evette S. , Das, Pritam , Batra, Jyotica, Hori, Tomohide , Baine, Ann-Marie T., Gardner, Lindsay B., Yue, Mei, Bu, Guojun , Zoppo, Gregory del, Patel, Tushar , Nguyen, Justin H. , Chen, Feng , Hata, Toshiyuki , Patel, Tushar , Bu, Guojun , Radisky, Evette S

Journal of Cerebral Blood Flow & Metabolism | March 27, 2013 | Volume: 33 | Issue: 7 | Pages: 1041-1049

10.1038/jcbfm.2013.45 | PMID 23532086 Get It

Blood-brain barrier (BBB) dysfunction in acute liver failure (ALF) results in increased BBB permeability that often precludes the patients from obtaining a life-saving liver transplantation. It remains controversial whether matrix metalloproteinase-9 (MMP-9) from the injured liver contributes to the deregulation of BBB function in ALF. We selectively upregulated a physiologic inhibitor of MMP-9 (TIMP-1) with a single intracerebroventricular injection of TIMP-1 cDNA plasmids at 48 and 72 hours, or with pegylated-TIMP-1 protein. Acute liver failure was induced with tumor necrosis factor-α and D-(+)-galactosamine in mice. Permeability of BBB was assessed with sodium fluorescein (NaF) extravasation. We found a significant increase in TIMP-1 within the central nervous system (CNS) after the administration of TIMP-1 cDNA plasmids and that increased TIMP-1 within the CNS resulted in an attenuation of BBB permeability, a reduction in activation of epidermal growth factor receptor and p38 mitogen-activated protein kinase signals, and a restoration of the tight junction protein occludin in mice with experimental ALF. Pegylated TIMP-1 provided similar protection against BBB permeability in mice with ALF. Our results provided a proof of principle that MMP-9 contributes to the BBB dysfunction in ALF and suggests a potential therapeutic role of TIMP-1 in ALF.
Response to Letter Regarding Article, “Endovascular Treatment of Intracranial Aneurysms With Flow-Diverters: A Meta-Analysis”
Brinjikji, Waleed , Murad, M. Hassan , Kallmes, David F. , Murad, M Hassan

Stroke | March 27, 2013 | Volume: 44 | Issue: 5 | Pages: No page available

10.1161/strokeaha.113.001028 | PMID 23741739 Get It

Pituitary Stalk Lesions: The Mayo Clinic Experience
Lin, Eleanor , Guadalix, Sonsoles, Schwartz, Kara M., Scheithauer, Bernd W., Atkinson, John L. D., Turcu, Adina F. , Erickson, Bradley J. , Young, William F.

The Journal of Clinical Endocrinology & Metabolism | March 27, 2013 | Volume: 98 | Issue: 5 | Pages: 1812-1818

10.1210/jc.2012-4171 | PMID 23533231 Get It

Regulation of growth hormone secretion
Norman, Catalina, Veldhuis, Johannes D.

Acromegaly: Diagnosis & Treatment | March 26, 2013 | Volume: No volume available | Issue: No issue available | Pages: 38-53

10.2217/ebo.12.59 Get It

Biomarkers-guided targeted drugs: new clinical trials design and practice necessity
An, Ming‐Wen , Mandrekar, Sumithra J. , Sargent, Daniel J.

Advances in personalized cancer management | March 26, 2013 | Volume: No volume available | Issue: No issue available | Pages: 30-41

10.2217/ebo.11.87 Get It